Introduction
============

At present, the aging phenomenon of social population is increasingly obvious. The incidence of diabetes mellitus (DM) is higher each year all over the world as a result of many factors such as genetic factors, environment and social life style ([@b1-etm-0-0-6718]). The latest survey data show that in China there are \>30 million DM patients aged \>45 years ([@b2-etm-0-0-6718]), and most of the patients with chronic renal insufficiency are DM patients whose common clinical manifestation are proteinuria and gradual decline of renal function ([@b3-etm-0-0-6718]). With a rather complex pathogenesis, type 2 DM is the main type among DM patients. The inflammatory response plays important roles in the occurrence and development of diabetic nephropathy. C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) play main roles in promoting the inflammatory response among the systemic inflammatory responses, regulating the patient\'s immune and inflammatory response system ([@b4-etm-0-0-6718],[@b5-etm-0-0-6718]). Numerous studies have concluded that the long-term blood hypercoagulability is one of the major causes of impaired renal function in DM patients ([@b6-etm-0-0-6718]). In the presence of proteinuria in patients with diabetic nephropathy, the activity of coagulation factors in plasma is stronger than that in the normal organism. In particular, endogenous coagulation factors affect coagulation function in patients with one another ([@b7-etm-0-0-6718]). On the other hand, the number of glomerular and tubular interstitial capillaries of patients with diabetic nephropathy is smaller than that in the normal organism. The decrease in the number of capillaries is mainly due to apoptosis and clearance of vascular endothelial cells ([@b8-etm-0-0-6718]). In the adult organism, the normal function of the vascular endothelial cells is maintained through continuous proliferation of vascular endothelial cells to form new vascular histiocytic germs ([@b9-etm-0-0-6718]). Vascular endothelial cell is also one of the most important human endocrine tissues, which can synthesize and release a large amount of vasoactive substances, affecting vital organs of the body such as kidney and liver ([@b7-etm-0-0-6718]). Therefore, investigating the relationships of vascular endothelial function and coagulation factors with renal function and levels of serum inflammatory factors in patients with diabetic nephropathy may provide a new clinical reference value for the diagnosis and treatment of patients with diabetic nephropathy.

Patients and methods
====================

### General data

A total of 86 patients diagnosed with DM and admitted to the 89th Hospital of the People\'s Liberation Army (Weifang, China) from March 2014 to May 2017 were selected. Among them, 38 patients with nephropathy were divided into the observation group and 48 patients without nephropathy into the control group. There were 45 males and 41 females aged 45--78 years with an average age of 52.73±8.68 years. The patients enrolled met the diagnostic criteria of World Health Organization (WHO) type 2 DM of 1997. The diagnostic criteria of diabetic nephropathy were based on renal function, 24-h urinary protein and urinary protein-creatinine ratio. Exclusion criteria: i) patients with severe systemic infection; ⅱ) patients who used estrogen, anti-coagulant or thrombolytic drugs; ⅲ) patients with malignant tumor; ⅳ) patients with autoimmune diseases; v) patients with severe liver and kidney dysfunction; ⅵ) patients with mental illness; and ⅶ) patients with missing clinical data or who refused to sign the informed consent.

The study was approved by the Ethics Committee of the 89th Hospital of the People\'s Liberation Army. Patients who participated in this study or their guardians, signed informed consent and had complete clinical data.

### Methods

All clinical data of patients including age, sex, height, weight and duration of DM were retrospectively analyzed. Fasting peripheral blood in all the patients after fasting and water deprivation overnight for 10 h were collected. The upper serum was taken to determine the relevant biochemical indicators. The fasting plasma glucose (FPG) was determined by glucose oxidase method. The glycated hemoglobin (HbA1c) was detected via glycohemoglobin analyzer. The fasting insulin (FINS) level was estimated via radioimmunity method with the kit provided by Beijing Kepu Science and Technology Co., Ltd. (Beijing, China). The levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and renal function indicators such as cystatin-C (Cys-C), serum creatinine (SCr), urea, β2-microglobulin were detected by the automatic biochemistry analyzer (Beckman-700, Fullerton, CA, USA). The levels of CRP, TNF-α and IL-6 were determined through immune turbidimetry. Immunomagnetic bead assay was used to detect the fibrinogen (FIB), prothrombin time (PT) and activated partial thromboplastin time (APTT). Homocysteine (Hcy) and nitric oxide (NO) were detected through enzyme-linked immunosorbent assay (ELISA). Brachial artery blood flow and endothelium-dependent vasodilation through flow-mediated dilation (FMD) were measured via two-dimensional ultrasound.

### Statistical analysis

Statistical Product and Service Solutions (SPSS; IBM Corp., Armonk, NY, USA) 19.0 software was used for data processing. Data were collected and presented as (means ± SD), and Chi-square test was used for the comparison of enumeration data. Pearsons correlation analysis was used between the two factors. P\<0.05 suggested that the diffidence was statistically significant.

Results
=======

### Comparison of general information between the observation and control groups

The differences in age, sex, body mass index (BMI), TC, TG, LDL-C and HDL-C were not statistically significant between the observation and control groups. However, the DM duration in the observation group was longer than that in the control group, and levels of HbA1c, FPG and FINS were significantly higher than those in the control group. All the differences were statistically significant (p\<0.05, [Table I](#tI-etm-0-0-6718){ref-type="table"}).

### Comparison of vascular endothelial functions between the observation and control groups

In the observation group, the peripheral serum Hcy and brachial artery blood flow were higher than those in the control group, and NO and FMD levels were lower than those in the control group. The differences were statistically significant (p\<0.05, [Table II](#tII-etm-0-0-6718){ref-type="table"}).

### Comparison of coagulation functions between the observation and control groups

As for the comparison between the two groups of patients, the difference in PT between the observation and control groups was not significant. But the level of FIB in the observation group was higher than that in the control group and APTT was shorter than that in the control group. All the differences were statistically significant (p\<0.05, [Table III](#tIII-etm-0-0-6718){ref-type="table"}).

### Comparison of renal function levels between the observation and control groups

The peripheral serum Cys-C, SCr, urea and β2-microglobulin levels in observation group were significantly higher than those in the control group and the differences were statistically significant (p\<0.05, [Table IV](#tIV-etm-0-0-6718){ref-type="table"}).

### Comparison of levels of peripheral serum inflammatory factors between the observation and control groups

Levels of peripheral serum CRP, TNF-α, IL-6 in the observation group were significantly higher than those in the control group and the differences were statistically significant (p\<0.05, [Table V](#tV-etm-0-0-6718){ref-type="table"}).

### Analysis of correlation of vascular endothelial function and coagulation factors with renal function and inflammatory factors

SCr (r=−0.683, p\<0.001) and CRP (r=−0.696, p\<0.001) were negatively correlated with NO. SCr (r=0.713, p\<0.001) and CRP (r=0.747, p\<0.001) were positively correlated with FIB ([Figs. 1](#f1-etm-0-0-6718){ref-type="fig"}--[4](#f4-etm-0-0-6718){ref-type="fig"}).

Discussion
==========

With the continuous changes in social lifestyle, including living environment, dietary habits and other changes, the incidence of DM is increasing. In particular, the incidence of DM is approximately 10% in China, most of which is type 2 DM ([@b10-etm-0-0-6718]). The dysfunction of blood glucose regulation results in the various target organ dysfunctions in the whole body. Vascular disease is the most common disease found in clinic. Diabetic nephropathy is one of the most common complications, which is manifested as impaired renal function and the presence of proteinuria ([@b8-etm-0-0-6718]). Diabetic nephropathy is a common cause of clinical chronic renal failure among many others, and the overreaction of inflammatory system plays an important pathogenic role in diabetic nephropathy ([@b11-etm-0-0-6718]). Type 2 DM is often complicated with metabolic imbalance in adipocytes, which can produce more inflammatory factors than normal levels and thus resulting in an inflammatory response ([@b12-etm-0-0-6718]). The combination of diabetes with renal injury leads to the severe ongoing inflammatory system response ([@b13-etm-0-0-6718]). CRP, TNF-α and other factors play an important role in the inflammatory system response process. The inflammatory response causes the occurrence and aggravation of atherosclerosis, which is also an important factor contributing to the death of patients with diabetic nephropathy ([@b14-etm-0-0-6718]). The major role of IL-6 is to regulate the immune system and to transmit important information in the inflammatory system responses. TNF-α can enhance the stress response of cells to the inflammatory reaction, lead to insulin resistance and accelerate the renal injury in DM patients ([@b15-etm-0-0-6718]). It was found in this study that the levels of peripheral inflammatory factors in DM patients complicated with nephropathy were significantly higher than those in patients with simple DM, and the differences were statistically significant, which is consistent with the above conclusion (p\<0.05).

Numerous studies have shown that DM patients have blood systems which are often manifested as hypercoagulability, and they are more prone to the thrombosis compared with healthy people ([@b6-etm-0-0-6718]). DM patients often have different degrees of thrombosis which results in increased mortality ([@b16-etm-0-0-6718]). Relevant data reveal that the thrombus activation for DM patients is stronger than that for normal body. A variety of plasma coagulation factors are increased in patients with DM, further aggravating renal injury ([@b17-etm-0-0-6718]). It was shown in this study that the levels of renal function-related indicators in patients with diabetic nephropathy were significantly higher than those in diabetic patients without renal injury and APTT was shorter, suggesting that patients with diabetic nephropathy have enhanced endogenous coagulation function. The main pathologic and physiological manifestations of DM patients are increased content of extracellular matrix, increased quantity of mesangial cells and glomerular sclerosis ([@b18-etm-0-0-6718]). Long duration of DM, long-term poor blood glucose control, endocrine metabolic disorders, the change of glomerular hemodynamics and other reasons are the main factors leading to the occurrence and aggravation of diabetic nephropathy ([@b19-etm-0-0-6718]). On the other hand, impaired vascular endothelial function is also closely related to diabetic nephropathy. Patients with long-term hyperglycemia are prone to vascular endothelial dysfunction; disorder of the active substances released from vascular synthesis, decreased level of vasodilator active factor and increased content of vasoconstrictor factors, and they are also easier to have vascular contracture and be exposed to the increased risk of thrombosis ([@b20-etm-0-0-6718]). It was concluded in the study that the blood of patients with diabetic nephropathy is hypercoagulable, and the degree of vascular endothelial dysfunction is more severe than that in patients only with diabetes. The difference was statistically significant (p\<0.05). Therefore, paying close attention to the peripheral serum inflammatory factors, coagulation factors and endothelial function in patients with diabetic nephropathy will help to determine and treat the disease, improve the prognosis, reduce mortality and provide new ideas for the treatment of patients with diabetic nephropathy.
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###### 

Comparison of general information between the observation and control groups.

  General information   Observation group (n=38)   Control group (n=48)   P-value
  --------------------- -------------------------- ---------------------- ---------
  Age (years)           53.17±8.36                 51.93±7.93             0.682
  Sex (male/female)     20/18                      25/23                  0.591
  BMI (kg/m^2^)         23.91±3.82                 24.08±2.77             0.424
  DM duration (years)   10.79±2.53                 6.36±3.17              0.013
  HbA1c (%)             10.99±1.47                 7.23±1.05              0.003
  FPG (mmol/l)          11.39±1.76                 8.27±0.95              0.001
  FINS (mIU/l)          13.75±2.41                 9.79±2.34              0.001
  TC (mmol/l)           5.75±1.21                  4.84±1.05              0.071
  TG (mmol/l)           1.95±1.03                  1.93±0.98              0.116
  LDL-C (mmol/l)        3.11±0.97                  2.97±0.86              0.493
  HDL-C (mmol/l)        1.48±0.51                  1.43±0.29              0.078

BMI, body mass index; DM, diabetes mellitus; HbA1c, glycated hemoglobin; FPG, fasting plasma glucose; FINS, fasting insulin; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.

###### 

Comparison of vascular endothelial function between the observation and control groups.

  Related index                         Observation group (n=38)   Control group (n=48)   P-value
  ------------------------------------- -------------------------- ---------------------- ---------
  Hcy (µmol/l)                          29.56±4.57                 13.23±2.91             0.001
  NO (µmol/l)                           41.87±9.86                 69.85±11.78            0.013
  Brachial artery blood flow (ml/min)   79.79±26.31                71.33±25.29            0.019
  FMD (%)                               3.49±0.26                  4.73±0.41              0.001

Hcy, homocysteine; NO, nitric oxide; FMD, flow-mediated dilation.

###### 

Comparison of coagulation function between the observation and control groups.

  Coagulation function   Observation group (n=38)   Control group (n=48)   P-value
  ---------------------- -------------------------- ---------------------- ---------
  FIB (g/l)              4.49±0.83                  2.82±0.76              0.026
  PT (sec)               11.93±1.31                 12.08±1.45             0.573
  APTT (sec)             30.88±2.79                 35.06±3.07             0.046

FIB, fibrinogen; PT, prothrombin time; APTT, activated partial thromboplastin time.

###### 

Comparison of renal function levels between the observation and control groups.

  Related index             Observation group (n=38)   Control group (n=48)   P-value
  ------------------------- -------------------------- ---------------------- ---------
  Cys-C (µmol/l)            1.47±0.35                  0.96±0.17              0.001
  SCr (µmol/l)              67±9                       38±4                   0.001
  Urea (mmol/l)             5.7±0.8                    2.9±0.5                0.001
  β2-microglobulin (mg/l)   4.3±0.3                    2.7±0.2                0.001

Cys-C, cystatin-C; SCr, serum creatinine.

###### 

Comparison of levels of serum inflammatory factors between the observation and control groups.

  Inflammatory factor   Observation group (n=38)   Control group (n=48)   P-value
  --------------------- -------------------------- ---------------------- ---------
  CRP (mg/l)            5.51±1.45                  2.43±0.99              0.001
  TNF-α (ng/ml)         10.98±1.34                 6.07±1.12              0.001
  IL-6 (µg/l)           9.57±1.65                  6.82±1.39              0.001

CRP, C-reactive protein; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6.
